Works matching IS 0167-6806 AND VI 212 AND IP 3 AND DT 2025

Results: 18

National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 531, doi. 10.1007/s10549-025-07750-2

By:

Cohen, Lauren N.;
Rogers, Christine C.;
Lloren, Jan Irene C.;
Kamaraju, Sailaja;
Chaudhary, Lubna N.;
Huang, Chiang-Ching;
Cobb, Adrienne N.;
Singh, Puneet;
Kong, Amanda L.;
Teshome, Mediget;
Cortina, Chandler S.

Publication type:

Article

PD-L1 22C3 CPS in paired primary breast cancer and lung metastasis.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 569, doi. 10.1007/s10549-025-07757-9

By:

Shin, Eunah;
Cha, Yoon Jin;
Kim, Hye Min;
Koo, Ja Seung

Publication type:

Article

Correction: Evaluating the impact of histological vs. nuclear grading on CPS + EG Score for HR + /HER2-early breast cancer.

Published in:

2025

By:

Braun, M.;
Hamann, M.;
Hanusch, C.;
Andrulat, A.;
Bensmann, E.;
Pölcher, M.;
Beer, M.;
Huber, E.

Publication type:

Correction Notice

Mammographic calcifications association with risk of advanced breast cancer.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 555, doi. 10.1007/s10549-025-07753-z

By:

Kerlikowske, Karla;
Abraham, Linn;
Sprague, Brian L.;
Sattayapiwat, Olivia;
Nyante, Sarah J.;
Tice, Jeffrey A.;
Miglioretti, Diana L.

Publication type:

Article

Effect of pretreatment lab abnormalities on the time-to-treatment discontinuation and overall survival of metastatic breast cancer patients receiving CDK 4/6i, PI3Ki, and/or mTORi.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 545, doi. 10.1007/s10549-025-07751-1

By:

Franks, Jeffrey;
Azuero, Andres;
Kenzik, Kelly;
Jahan, Nusrat;
Fowler, Mackenzie;
Griffin, Russell;
Rocque, Gabrielle

Publication type:

Article

Local treatment of ipsilateral breast cancer recurrence: a sensitive decision-making process.

Published in:

2025

By:

Hannoun-Levi, Jean-Michel;
Strnad, Vratislav;
Polgar, Csaba

Publication type:

Letter

Phase I/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1/2 positive, HER2 negative breast cancers.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 521, doi. 10.1007/s10549-025-07747-x

By:

Phadke, Sneha;
Miller, Kathy D.;
Shah, Ami;
Danciu, Oana C.;
Chen, Yi;
Yu, Menggang;
Burkard, Mark E.;
Wisinski, Kari B.

Publication type:

Article

Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: a systematic review and meta-analysis.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 427, doi. 10.1007/s10549-025-07746-y

By:

Liutti, Vitor Teixeira;
do Vale, David Laios;
de Souza, Bruno Lins;
Manea, Rafael Ricci Ferrari;
Araújo, Daniel Vilarim

Publication type:

Article

Continuous glucose monitoring to characterize hyperglycemia during chemotherapy for early stage breast cancer.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 511, doi. 10.1007/s10549-025-07745-z

By:

Ulene, Sophie R.;
Wang, Shikun;
Cook, Joshua R.;
McAuley, Fiona;
Wooster, Margaux E.;
Faheem, Khadija F.;
Varoli, Andrew;
McGuinness, Julia E.;
Vasan, Neil;
Trivedi, Meghna S.;
Crew, Katherine D.;
Harden, Erik;
Law, Cynthia;
Hershman, Dawn L.;
Accordino, Melissa K.

Publication type:

Article

Tumoral pSMAD2 as a prognostic biomarker in early-stage breast cancer: insights from the randomized SweBCG91RT trial.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 499, doi. 10.1007/s10549-025-07744-0

By:

Stenmark Tullberg, Axel;
Thurfjell, Viktoria;
Kovács, Anikó;
Micke, Patrick;
Moustakas, Aristidis;
Killander, Fredrika;
Niméus, Emma;
Holmberg, Erik;
Karlsson, Per;
Strell, Carina

Publication type:

Article

Promoting resilience in stress management (PRISM) for patients with early stage breast cancer: a pilot feasibility study.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 487, doi. 10.1007/s10549-025-07741-3

By:

Rocque, Gabrielle B;
Olguin, Etzael Ortiz;
Shuey, Jessi M.;
Padalkar, Tanvi;
Williams, Courtney P.;
Azuero, Andres;
Falcao, Ana;
Henderson, Nicole L.;
Taub, Chloe J.;
Ream, Molly;
Yi-Frazier, Joyce P.;
Junkins, Courtney C.;
Reeder-Hayes, Katherine;
Rosenberg, Abby R.

Publication type:

Article

Utility of plasma circulating DNA tumor fraction in bone-only metastatic breast cancer: a real-world outcomes study.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 475, doi. 10.1007/s10549-025-07740-4

By:

Bader, Gilbert;
Quintanilha, Julia C. F.;
Veney, Deloris;
Graf, Ryon P.;
Levy, Mia;
Pasquina, Lincoln W.;
Stover, Daniel G.

Publication type:

Article

Severe hyponatremia with abemaciclib use in the absence of pre-existing renal disease.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 435, doi. 10.1007/s10549-025-07739-x

By:

Kim, Tae Hoon;
Podolski, Amanda;
Teplinsky, Eleonora

Publication type:

Article

Breast imaging recommendations for young females (age < 40 years) with ≥ 20% lifetime breast cancer risk: practice patterns at a specialized clinic.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 467, doi. 10.1007/s10549-025-07738-y

By:

Wehbe, Alexandra;
Katlin, Fisher;
Sharma, Eshita;
Hans, Marybeth;
Graichen, Mary Knust;
Bychkovsky, Brittany L.;
Scheib, Rochelle;
Garber, Judy E.;
Pace, Lydia E.;
King, Tari A.;
Laws, Alison

Publication type:

Article

Efficacy and safety of entinostat plus exemestane in hormone receptor-positive breast cancer: a systematic review meta-analysis of randomized controlled trials.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 417, doi. 10.1007/s10549-025-07737-z

By:

Mustafa, Nour Maher;
Mustafa, Mus'ab Theeb;
Abushanab, Aws Khalid;
Alakhras, Hamza Muneer;
Abed, Anas Saed;
Bani-Said, Sereen Ahmad;
Othman, Laith Sami;
Shdaifat, Areen

Publication type:

Article

Insurer and patient costs for repeat breast surgery after initial lumpectomy for breast cancer.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 457, doi. 10.1007/s10549-025-07735-1

By:

Wing, Sam E.;
Liu, Yuki;
Zheng, Feibi;
Hamm, Naomi C.;
Dekhne, Nayana S.;
Selber, Jesse C.

Publication type:

Article

A mixed-methods study characterizing experiences of medical oncologists' use of gonadotropin-releasing hormone agonists for treatment of breast cancer.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 449, doi. 10.1007/s10549-025-07734-2

By:

Lee, Kimberley T.;
Hu, Bihe;
Martinez Tyson, Dinorah;
Geiss, Carley;
Vadaparampil, Susan T.;
Jim, Heather S. L.;
Gwede, Clement K.;
Soliman, Hatem H.;
Henry, N. Lynn;
Hershman, Dawn L.

Publication type:

Article

Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.

Published in:

Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 437, doi. 10.1007/s10549-025-07710-w

By:

Medford, Arielle J.;
Velimirovic, Marko;
Gefen, Yifat;
Niemierko, Andrzej;
Gerratana, Lorenzo;
Davis, Andrew A.;
Clifton, Katherine;
Keenan, Jennifer;
Podany, Emily;
Hensing, Whitney L.;
Reduzzi, Carolina;
Dai, Charles S.;
Kiedrowski, Lesli A.;
Spring, Laura M.;
Ellisen, Leif W.;
Doebele, Robert C.;
Cristofanilli, Massimo;
Getz, Gad;
Bardia, Aditya

Publication type:

Article